Straumann Holding AG's revenue for the
six
months ended in Jun. 2024 was €1,323 Mil.
Its revenue for the trailing twelve months (TTM) ended in Jun. 2024 was €2,668 Mil.
Straumann Holding AG's Revenue per Share for the
six
months ended in Jun. 2024 was €0.83.
Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was €1.67.
Good Sign:
Straumann Holding AG has shown predictable revenue and earnings growth.
During the past 12 months, the average Revenue per Share Growth Rate of Straumann Holding AG was 11.20% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 19.10% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 13.00% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 14.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 13 years, Straumann Holding AG's highest 3-Year average Revenue per Share Growth Rate was 22.50% per year. The lowest was -3.90% per year. And the median was 13.20% per year.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Straumann Holding AG's Revenue
For the Medical Instruments & Supplies subindustry, Straumann Holding AG's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Straumann Holding AG's Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Straumann Holding AG's Revenue distribution charts can be found below:
* The bar in red indicates where Straumann Holding AG's Revenue falls into.
Straumann Holding AG Revenue Calculation
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €2,668 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Straumann Holding AG (FRA:QS50) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Straumann Holding AG Revenue Related Terms
Thank you for viewing the detailed overview of Straumann Holding AG's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The company's core products are dental implants, and it holds roughly one third of the global implant dentistry market, which is estimated to be worth roughly CHF 5.4 billion. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:QS50 has been successfully added to your 